Zainul S Hasanali - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Oncotarget|September 12, 2022

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphomaFrancis R LeBlanc, Zainul S Hasanali, August Stuart, et al.

Blood|August 24, 2023

Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapyYan Tang, Wei Liu, Siddhant Kadu, et al.

Biorxiv : the Preprint Server for Biology|February 6, 2026

The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy targetZhiwei Ang, Annette Castro, Luca Paruzzo, et al.

Nature Medicine|January 15, 2026

CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapyMatthew Ho, Luca Paruzzo, Julia Han Noll, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Oncotarget|September 12, 2022

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphomaFrancis R LeBlanc, Zainul S Hasanali, August Stuart, et al.

Blood|August 24, 2023

Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapyYan Tang, Wei Liu, Siddhant Kadu, et al.

Biorxiv : the Preprint Server for Biology|February 6, 2026

The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy targetZhiwei Ang, Annette Castro, Luca Paruzzo, et al.

Nature Medicine|January 15, 2026

CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapyMatthew Ho, Luca Paruzzo, Julia Han Noll, et al.

Pageof 2